| Subjects | Dosages for patient weight mg | ||
| <45 kg | ≥45 kg | ||
| Single drug use group | |||
| Kanamycin | 15 (51.7) | 500 q.d. | 750 q.d. |
| Capreomycin | 12 (41.4) | 500 q.d. | 750 q.d. |
| Amikacin | 2 (6.8) | 500 q.d. | 750 q.d. |
| Levofloxacin | 12 (41.4) | 750 q.d. | 750 q.d. |
| Moxifloxacin | 17 (58.6) | 400 q.d. | 400 q.d. |
| Ethionamide | 14 (48.3) | 250 b.i.d. | 750 in divided doses |
| Clofazimine | 12 (41.4) | 200 q.d. | 200 q.d. |
| Prothionamide | 11(37.9) | 250 b.i.d. | 750 in divided doses |
| PAS | 19 (65.5) | 10000 in divided doses | 12000 in divided doses |
| Cycloserine | 10 (34.4) | 250 b.i.d. | 750 in divided doses |
| Amoxycillin-clavulanic acid | 23 (79.3) | 625 t.i.d./1000 b.i.d. | 625 t.i.d./1000 b.i.d. |
| Linezolid# | 29 (100) | ||
| High dose | 11(37.9) | 600 b.i.d. | 600 b.i.d. |
| Low dose | 18 (62.1) | 600 q.d. | 600 q.d. |
| Drug combination group¶ | |||
| L+I+Q+2 drugs | 3 (10.3) | ||
| L+I+Q+3 drugs | 16 (55.2) | ||
| L+I+Q+4 drugs | 6 (20.7) | ||
| L+I+Q+5 drugs | 4 (13.8) | ||
Data are presented as n (%), unless otherwise stated. PAS: para-aminosalicylic acid; L: linezolid; I: injectable; Q: quinolone. #: linezolid was given either as low dose (600 mg q.d.) or high dose (600 mg b.i.d.); ¶: median (interquartile range) number of drugs used was 6 (6–7).